Template:Sodium channel blocking toxidromes: Difference between revisions
(Created page with "*Phenothiazines *Antihistamines *Sotalol *TCAs *Antipsychotics *Cocaine *Anti-spasmodics, cyclobenzaprine *Chloroquine *Anti-malarials *Class Ib antiarrhythmics") |
|||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
===Sodium Channel Blockade Toxidrome=== | |||
*Phenothiazines | *Phenothiazines | ||
*Antihistamines | *Antihistamines | ||
*Sotalol | *Sotalol | ||
*TCAs | *[[Tricyclic antidepressant (TCA) toxicity|TCAs]] | ||
*Antipsychotics | *Antipsychotics | ||
*Cocaine | *[[Cocaine toxicity|Cocaine]] | ||
*Anti-spasmodics, cyclobenzaprine | *Anti-spasmodics, cyclobenzaprine | ||
*Chloroquine | *Chloroquine | ||
*Anti-malarials | *Anti-malarials | ||
*Class | *Class Ia and Ic antiarrhythmics | ||
*[[Local anesthetic systemic toxicity]] | |||
*[[Venlafaxine]] toxicity | |||
Latest revision as of 13:56, 1 September 2019
Sodium Channel Blockade Toxidrome
- Phenothiazines
- Antihistamines
- Sotalol
- TCAs
- Antipsychotics
- Cocaine
- Anti-spasmodics, cyclobenzaprine
- Chloroquine
- Anti-malarials
- Class Ia and Ic antiarrhythmics
- Local anesthetic systemic toxicity
- Venlafaxine toxicity
